Adoption of Biologically Effective Dose of the Non-Target Lung Volume to Predict Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy With Variable Fractionations for Lung Cancer

Adoption of Biologically Effective Dose of the Non-Target Lung Volume to Predict Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy With Variable Fractionations for Lung Cancer

Background: This study aims to establish lung biologically effective dose (BED)–based uniform dosimetric constraints for minimizing the risk of symptomatic radiation pneumonitis (SRP) from stereotactic body radiation therapy (SBRT) using variable fractionations in patients with lung tumors.Materials...

Full description

Bibliographic Details
Main Authors: Yuxin Jiao, Yanping Ren, Weiqiang Ge, Libo Zhang, Xiangpeng Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Oncology
Subjects:
lung cancer
stereotactic body radiation therapy (SBRT)
radiation pneumonitis
biological effective dose (BED)
risk factors
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01153/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01153/full

Similar Items